Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of gap junction assembly. [GO_REF:0000058, GOC:BHF, GOC:mtg_cardiac_conduct_nov11, GOC:rl, GOC:TermGenie, PMID:25017399]
Gap junctions are specialized intercellular channels that allow direct communication between adjacent cells. They are formed by the alignment of connexon hemichannels from neighboring cells. Each connexon is composed of six connexin proteins, which assemble into a hexameric structure. The regulation of gap junction assembly is a complex process that involves multiple steps, including:
1. **Transcription and translation of connexin genes:** The expression of connexin genes is regulated by a variety of factors, including developmental stage, cell type, and external stimuli.
2. **Connexin trafficking and delivery to the plasma membrane:** Connexins are synthesized in the endoplasmic reticulum (ER) and then transported to the Golgi apparatus, where they are sorted and packaged into transport vesicles. These vesicles then fuse with the plasma membrane, delivering the connexins to the cell surface.
3. **Connexon docking and assembly:** Once at the plasma membrane, connexins interact with each other to form connexons. Connexons from neighboring cells then dock and align to form gap junctions.
4. **Gap junction gating:** Gap junctions can be open or closed, regulating the flow of ions and small molecules between cells. This gating can be regulated by a variety of factors, including pH, calcium levels, and phosphorylation.
Several key factors influence the regulation of gap junction assembly. These include:
* **Cell-cell adhesion:** Cadherins and other cell adhesion molecules play a role in bringing cells into close proximity, facilitating gap junction formation.
* **Cytoskeletal interactions:** The cytoskeleton provides structural support for gap junctions and helps regulate their localization and stability.
* **Signaling pathways:** Various signaling pathways, including those involving protein kinases and phosphatases, regulate connexin expression, trafficking, and assembly.
The regulation of gap junction assembly is essential for a wide range of physiological processes, including:
* **Intercellular communication:** Gap junctions allow for the rapid and direct exchange of ions, metabolites, and signaling molecules between cells, enabling coordinated cellular responses.
* **Tissue development:** Gap junctions play critical roles in embryonic development, cell differentiation, and tissue morphogenesis.
* **Tissue homeostasis:** Gap junctions maintain tissue function and integrity by coordinating cellular activity and facilitating the exchange of nutrients and waste products.
* **Immune response:** Gap junctions are involved in the communication between immune cells, facilitating immune responses and inflammation.
Dysregulation of gap junction assembly can contribute to various diseases, including:
* **Cardiovascular disease:** Gap junctions are essential for proper heart function, and disruptions in their assembly can lead to arrhythmias and heart failure.
* **Neurological disorders:** Gap junctions play critical roles in neuronal communication and brain development. Defects in gap junction assembly can contribute to epilepsy, neurodevelopmental disorders, and other neurological conditions.
* **Cancer:** Altered gap junction communication can contribute to tumor growth and metastasis.
In conclusion, the regulation of gap junction assembly is a complex and tightly controlled process that is essential for normal cell function and tissue homeostasis. Understanding the molecular mechanisms involved in this process is critical for developing new therapies for diseases associated with dysregulation of gap junction function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Apelin receptor | An apelin receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P35414] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
4-oxo-6-((pyrimidin-2-ylthio)methyl)-4h-pyran-3-yl 4-nitrobenzoate | 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate: structure in first source | nitrobenzoic acid | |
apelin-13 peptide | apelin-13 : A 13 amino acid oligopeptide which is the ligand for the apelin receptor (also known as the APJ receptor). It exhibits hypotensive and neuroprotective effects, and may be a potential prognostic biomarker for acute ischemic stroke and multiple sclerosis. apelin-13 peptide: amino acid sequence in first source | oligopeptide | antihypertensive agent; autophagy inhibitor; biomarker; human metabolite; neuroprotective agent |
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe : A thirteen-membered polypeptide consisting of p-Glu, Arg, Pro, Arg, Leu, Ser, His, Lys, Gly, Pro, Met, Pro and Phe residues joined in sequence. | polypeptide | apoptosis inhibitor; human metabolite; neuroprotective agent |